LITTLE KNOWN FACTS ABOUT LEVITRABIS.COM.

Physicians should advise patients to halt use of all phosphodiesterase form five (PDE5) inhibitors, including LEVITRA, and search for healthcare consideration during the event of sudden lack of eyesight in one or both equally eyes. Such an occasion may be a indicator of nonarteritic anterior ischemic optic neuropathy (NAION), a rare condition and a